Next Article in Journal
Origin and Distribution of Thiophenes and Furans in Gas Discharges from Active Volcanoes and Geothermal Systems
Next Article in Special Issue
Modulation of Radiation-Induced Genetic Damage by HCMV in Peripheral Blood Lymphocytes from a Brain Tumor Case-Control Study
Previous Article in Journal
In Vivo Study of the Effects of Peptide-Conjugated Near-Infrared Fluorescent Quantum Dots on the Tumorigenic and Lymphatic Metastatic Capacities of Squamous Cell Carcinoma Cell Line Tca8113 and U14
Previous Article in Special Issue
Cancer Biomarkers: Are We Ready for the Prime Time?
Open AccessArticle

Differential Proteomics Identification of HSP90 as Potential Serum Biomarker in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry

1
Chengdu Medical College, Chengdu 610083, Sichuan Province, China
2
West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2010, 11(4), 1423-1433; https://doi.org/10.3390/ijms11041423
Received: 11 January 2010 / Revised: 14 March 2010 / Accepted: 17 March 2010 / Published: 31 March 2010
(This article belongs to the Special Issue Biomarkers)
The aim of the current study is to identify the potential biomarkers involved in Hepatocellular carcinoma (HCC) carcinogenesis. A comparative proteomics approach was utilized to identify the differentially expressed proteins in the serum of 10 HCC patients and 10 controls. A total of 12 significantly altered proteins were identified by mass spectrometry. Of the 12 proteins identified, HSP90 was one of the most significantly altered proteins and its over-expression in the serum of 20 HCC patients was confirmed using ELISA analysis. The observations suggest that HSP90 might be a potential biomarker for early diagnosis, prognosis, and monitoring in the therapy of HCC. This work demonstrates that a comprehensive strategy of proteomic identification combined with further validation should be adopted in the field of cancer biomarker discovery. View Full-Text
Keywords: proteomics; hepatocellular carcinoma; serum biomarker proteomics; hepatocellular carcinoma; serum biomarker
MDPI and ACS Style

Sun, Y.; Zang, Z.; Xu, X.; Zhang, Z.; Zhong, L.; Zan, W.; Zhao, Y.; Sun, L. Differential Proteomics Identification of HSP90 as Potential Serum Biomarker in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry. Int. J. Mol. Sci. 2010, 11, 1423-1433. https://doi.org/10.3390/ijms11041423

AMA Style

Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y, Sun L. Differential Proteomics Identification of HSP90 as Potential Serum Biomarker in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry. International Journal of Molecular Sciences. 2010; 11(4):1423-1433. https://doi.org/10.3390/ijms11041423

Chicago/Turabian Style

Sun, Yiyi; Zang, Zhihe; Xu, Xiaohong; Zhang, Zhonglin; Zhong, Ling; Zan, Wang; Zhao, Yan; Sun, Lin. 2010. "Differential Proteomics Identification of HSP90 as Potential Serum Biomarker in Hepatocellular Carcinoma by Two-dimensional Electrophoresis and Mass Spectrometry" Int. J. Mol. Sci. 11, no. 4: 1423-1433. https://doi.org/10.3390/ijms11041423

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop